Menu
Annual · values2025202420232022
Operating Cash Flow-98276 USD6.67 M USD10.91 M USD621293 USD
Depreciation & Amortization141542 USD171346 USD151512 USD146658 USD
Stock-Based Compensation191565 USD224190 USD
Capital Expenditures65361 USD387876 USD134662 USD197802 USD
Cash Flow from Investing-731031 USD-225875 USD-121162 USD-197802 USD
Cash Flow from Financing-3.59 M USD3.00 M USD-10.97 M USD-764374 USD
Dividends Paid
Stock Buybacks
Free Cash Flow-163637 USD6.28 M USD10.78 M USD423491 USD

Massimo Group Inc. is a leading company in the healthcare sector, primarily focusing on the development and production of innovative medical technologies. The company's core purpose is to enhance patient care by providing high-performance diagnostic and therapeutic solutions. Massimo Group Inc. is renowned for its cutting-edge advancements in non-invasive monitoring technologies, which play a crucial role in hospitals, clinics, and medical facilities worldwide. Products such as vital sign monitors and pulse oximeters are integral to its portfolio, contributing significantly to patient health and safety. The company engages with a wide array of healthcare professionals, including clinicians and emergency medical staff, supporting their operations with reliable and efficient equipment. As a critical player in the medical technology industry, Massimo Group Inc. is pivotal in driving improvements in healthcare delivery, emphasizing both accuracy and accessibility. With its commitment to continuous research and development, Massimo Group Inc. not only maintains a competitive edge but also upholds its position as a vital entity in the healthcare technology market.